RS-127445 hydrochloride
SIGMA/R2533 - ≥98% (HPLC), powder
Synonym: 2-
CAS Number: 199864-86-3
Empirical Formula (Hill Notation): C17H16FN3 · HCl
Molecular Weight: 317.79
MDL Number: MFCD11112196
Linear Formula: C17H16FN3 · HCl
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to tan |
| form | powder |
| InChI | 1S/C17H16FN3.ClH/c1-10(2) |
| InChI key | MKJPYBJBPRFMHL-UHFFFAOYSA |
| originator | Roche |
| Quality Level | 100 ![]() |
| SMILES string | Cl.CC(C)c1cc(nc(N)n1)-c2c |
| solubility | DMSO: ≥20 mg/mL |
| storage condition | desiccated |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | RS-127445 is a selective; high affinity; orally bioavailable serotonin 5-HT2B receptor antagonist. |
| Biochem/physiol Actions: | RS-127445 is a selective; high affinity; orally bioavailable serotonin 5-HT2B receptor antagonist. RS-127445 was found to have nanomolar affinity for the 5-HT2B receptor (pKi=9.5) and 1,000 fold selectivity for this receptor as compared to numerous other receptor and ion channel binding sites. |
| Features and Benefits: | This compound was developed by Roche . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS06 |
| Signal word | Danger |
| Hazard statements | H301 - H315 - H319 - H335 |
| Precautionary statements | P301 + P310 + P330 - P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | T |
| Risk Statements | 25-36 |
| Safety Statements | 26-45 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


